Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
Haisley KR, Hart KD, Nabavizadeh N, Bensch KG, Vaccaro GM, Thomas CR Jr, Schipper PH, Hunter JG, Dolan JP. Haisley KR, et al. Among authors: nabavizadeh n. Dis Esophagus. 2017 Jul 1;30(7):1-7. doi: 10.1093/dote/dox015. Dis Esophagus. 2017. PMID: 28475724
Yttrium-90 Radioembolization for BCLC Stage C Hepatocellular Carcinoma Comparing Child-Pugh A Versus B7 Patients: Are the Outcomes Equivalent?
Zu Q, Schenning RC, Jahangiri Y, Tomozawa Y, Kolbeck KJ, Kaufman JA, Al-Hakim R, Naugler WE, Nabavizadeh N, Kardosh A, Billingsley KG, Mayo SC, Orloff SL, Enestvedt KK, Maynard E, Ahn J, Lhewa D, Farsad K. Zu Q, et al. Among authors: nabavizadeh n. Cardiovasc Intervent Radiol. 2020 May;43(5):721-731. doi: 10.1007/s00270-020-02434-4. Epub 2020 Mar 5. Cardiovasc Intervent Radiol. 2020. PMID: 32140840
Correction to: Yttrium-90 Radioembolization for BCLC Stage C Hepatocellular Carcinoma Comparing Child-Pugh A Versus B7 Patients: Are the Outcomes Equivalent?
Zu Q, Schenning RC, Jahangiri Y, Tomozawa Y, Kolbeck KJ, Kaufman JA, Al-Hakim R, Naugler WE, Nabavizadeh N, Kardosh A, Billingsley KG, Mayo SC, Orloff SL, Enestvedt CK, Maynard E, Ahn J, Lhewa D, Farsad K. Zu Q, et al. Among authors: nabavizadeh n. Cardiovasc Intervent Radiol. 2020 Sep;43(9):1425-1426. doi: 10.1007/s00270-020-02554-x. Cardiovasc Intervent Radiol. 2020. PMID: 32548673
Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications.
Deig CR, Sutton TL, Beneville B, Trone K, Stratton A, Gunesch AN, Liu AI, Alrohaibani A, Mohebnasab M, Bassale S, Grossblatt-Wait A, Keith D, Attia F, Gilbert EW, Lopez CD, Kardosh A, Chen EY, Bensch KG, Nabavizadeh N, Thomas CR, Mayo SC, Sheppard BC, Grossberg A. Deig CR, et al. Among authors: nabavizadeh n. Cancers (Basel). 2022 Jan 26;14(3):609. doi: 10.3390/cancers14030609. Cancers (Basel). 2022. PMID: 35158877 Free PMC article.
Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma.
Chen EY, Kardosh A, Nabavizadeh N, Foster B, Mayo SC, Billingsley KG, Gilbert EW, Lanciault C, Grossberg A, Bensch KG, Maynard E, Anderson EC, Sheppard BC, Thomas CR Jr, Lopez CD, Vaccaro GM; OHSU Gastrointestinal Cancer Disease Group. Chen EY, et al. Among authors: nabavizadeh n. Cancer Med. 2023 Jun;12(12):12986-12995. doi: 10.1002/cam4.5971. Epub 2023 May 3. Cancer Med. 2023. PMID: 37132281 Free PMC article. Clinical Trial.
72 results